Insilico Medicine Appoints Sujata Rao, MD as Chief Medical Officer (IMAGE)

InSilico Medicine

Insilico Medicine Appoints Sujata Rao, MD as Chief Medical Officer

Caption

Insilico CMO Sujata Rao, MD played a pivotal role in the Company’s latest achievement, dosing the first patients with a generative AI-produced drug for IPF in a Phase II clinical study that represents a milestone for the Company and the industry.

Credit

Insilico Medicine

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.